Pharmacology 2008-01-01

CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.

C Prenn, A Heinemann, R Schuligoi, B A Peskar

Index: Pharmacology 81(3) , 236-40, (2008)

Full Text: HTML

Abstract

The majority of prostaglandins (PGs) are known to induce intestinal fluid secretion (enteropooling). In contrast, PGD(2) has been demonstrated to inhibit fluid secretion induced by other PGs. This study was aimed to investigate, by the use of selective agonists/antagonists, which type of PGD(2) receptor mediates this inhibitory effect. The DP1 agonist BW245C dose-dependently inhibited the enteropooling effect of 16,16-dimethyl-PGE(2). This inhibition was counteracted by the DP1 antagonist BWA868C. In contrast, the CRTH2 receptor does not seem to be involved in the anti-enteropooling effect of PGD(2), since the selective agonists 13,14-dihydro-15-keto-PGD(2) and 15(R)-15-methyl-PGD(2) were without effect. Therefore, our results suggest that the inhibitory effect of PGD(2) in the small intestine is mediated via activation of the DP1 receptor.Copyright 2008 S. Karger AG, Basel.

Related Compounds

  • 16,16-Dimethyl pro...
  • BW 245C
  • BW A868C

Related Articles:

Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions.

2015-01-01

[Sci. Rep. 5 , 16406, (2015)]

Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor control.

2004-10-19

[Circulation 110(16) , 2326-32, (2004)]

Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors.

2015-09-01

[Microvasc. Res. 101 , 127-34, (2015)]

Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation.

2009-04-01

[Nat. Chem. Biol. 5 , 236-43, (2009)]

Chronic prostaglandin E2 treatment induces the synthesis of the pain-related peptide substance P and calcitonin gene-related peptide in cultured sensory ganglion explants.

2010-10-01

[J. Neurochem. 115(2) , 363-72, (2010)]

More Articles...